NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
P/S ratio for NGM Biopharmaceuticals (NGM)
P/S ratio as of June 2024 (TTM): 29.1
According to NGM Biopharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 29.0994. At the end of 2023 the company had a P/S ratio of 16.1.
P/S ratio history for NGM Biopharmaceuticals from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 16.1 | 116.96% |
| 2022 | 7.41 | -58.18% |
| 2021 | 17.7 | -27.57% |
| 2020 | 24.5 | 104.69% |
| 2019 | 12.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.12 | -96.14% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 217.87% | 🇺🇸 USA |